SEC Form 4 · accession 0001683168-17-000638
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrey Semechkin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Mar 20, 2017
Accepted (ET)
Mar 22, 2017 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2017 | P | 6,500 | $1.66 | A | 1,521,750 | D | |
| Common Stock | Mar 21, 2017 | P | 500 | $1.60 | A | 1,522,250 | D | |
| Common Stock | Mar 22, 2017 | P | 3,000 | $1.69 | A | 1,525,250 | D | |
| Common StockF1 | holding | — | — | — | 53,334 | I | By Corporation |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Common Stock is owned by X-Master, Inc., a New Hampshire Corporation of which the reporting person is a sole shareholder.